Publications

Publications

1 filter applied. Clear filter

Op-Ed

America needs a confirmed leader at FDA — now

Mark McClellan, Scott Gottlieb, and Margaret Hamburg and Andy Slavitt

2022

Read More

Policy Brief

Enhancing the Accessibility and Utility of Drug Interaction Information in Prescription Drug Labeling

Nicholas R. Harrison, Sarah M. Sheehan, Mongthuong T. Tran, Jeanne Herndon, Eric
Brodsky, and Joseph A. Grillo

2021

Read More

Letter

FDA Commissioners Letter of Support for Rob Califf

Andrew von Eschenbach, MD, Scott Gottlieb, MD, Stephen Hahn, MD, Margaret Hamburg, MD, Jane Henney, MD, Mark McClellan, MD PhD

2021

Read More

Project Report

Characterizing the FDA’s Approach to Benefit-Risk Assessment throughout the Medical Product Life Cycle

Nicholas R. Harrison and Sarah Sheehan

2020

Read More